My research focuses on cardiovascular and metabolic diseases, with particular emphasis on cardiovascular risk factors, metabolic syndrome, hypertension, diabetes, and chronic kidney disease. I have extensive experience in large-scale cohort studies and randomized controlled trials, integrating epidemiological approaches with molecular and biochemical analyses. My work explores the roles of oxidative stress, inflammation, trace elements, and novel anthropometric and lipid indices in predicting cardiometabolic outcomes. I am particularly interested in translational research that bridges molecular medicine and population-based epidemiology, aiming to improve risk prediction models and preventive strategies for cardiovascular disease.